As the global race to find cures for infectious diseases gains momentum, it’s crucial that vaccine developers and clinical laboratories work closely together to provide effective treatments to the patients that need them most.
In this complimentary insight brief
, you’ll learn about the current landscape of one of the most threatening infectious diseases, as well as 5 key elements of successful Zika vaccine development you should be using now.
today to learn more about how we use our deep scientific expertise and global laboratory footprint to partner with vaccine developers to overcome some of today’s most complex infectious disease vaccine development challenges.
About the authors:
Wayne R. Hogrefe
, Ph.D., D (ABMLI), Vice President, Vaccine unit
Paul Rhyne, Ph.D., Scientific Director, Bioanalytical and ADME Immunoassay Services